Verge HealthTech Fund

Verge HealthTech Fund is a global early-stage venture capital firm dedicated to investing in transformative health technology companies that enhance healthcare access in underserved markets. The firm focuses on startups that improve healthcare quality, efficiency, and accessibility, particularly in emerging regions.

The fund's investment strategy targets early-stage companies, including those at the seed and Series A stages, with a geographical focus on Singapore, the United States, Australia, Spain, and the United Kingdom. Their portfolio spans various sectors within the healthcare industry, such as digital health platforms, clinical decision support systems, digital therapeutics, and healthcare SaaS solutions.

Verge HealthTech Fund's approach emphasizes active partnership with founders to build innovative and valuable solutions. Their portfolio includes companies like Tachin.ai, an AI-enabled healthcare network in the United States; Understanding Zoe, an AI platform for neurodivergent children in Australia; and Zoundream, an AI-powered infant voice analysis solution in Spain. The fund's commitment to impactful healthtech solutions aims to make quality healthcare accessible for all, particularly in underserved populations.